The Unexpected Return
For decades, diphtheria was a distant memory in Australia, largely eradicated by widespread vaccination efforts that began in the 1930s. However, recent
months have seen a disturbing resurgence, with outbreaks reported across the Northern Territory and Western Australia. The Melbourne Vaccine Education Centre notes that since March 23, 2026, 17 cases of respiratory diphtheria and 60 cases of cutaneous diphtheria have been recorded in the Northern Territory. The Kimberly region of Western Australia has also reported cases this year. This renewed presence serves as a stark reminder of the disease's potential, as tragically exemplified by a 2024 outbreak in Rajasthan’s Deeg, India, which led to the deaths of seven children. This incident underscored the vulnerability of communities with insufficient immunisation coverage and delayed medical access to the swift and fatal progression of diphtheria.
Understanding Diphtheria's Spread
Diphtheria is a bacterial infection caused by Corynebacterium diphtheriae, a pathogen known for producing a potent toxin. This bacterium primarily targets the throat and upper respiratory tract, but its effects can be systemic, potentially damaging the heart and nervous system. The transmission occurs through respiratory droplets expelled when an infected individual coughs or sneezes, and also via close personal contact. Even asymptomatic carriers can spread the bacteria, posing a silent threat. The renewed circulation of diphtheria is largely attributed to declining vaccination rates, the waning immunity in adults who may have missed crucial booster doses, and the increased global mobility that facilitates the pathogen's movement across borders. The disease can affect anyone, but it historically posed the greatest risk to unvaccinated children.
Recognizing the Symptoms
Early detection of diphtheria is crucial for effective treatment and preventing severe complications. The initial signs often mimic common respiratory illnesses, presenting as a sore throat, a mild fever, and general fatigue. However, a distinguishing characteristic of respiratory diphtheria is the development of a thick, greyish membrane that forms over the throat or tonsils, which can severely impede breathing. Affected individuals may also experience swollen neck glands, a condition sometimes described as a 'bull neck' appearance. In cases of cutaneous diphtheria, the infection manifests as persistent skin ulcers covered by a similar dirty-grey membrane. The systemic impact of the diphtheria toxin can lead to rapid deterioration, making prompt recognition and medical intervention paramount.
Treatment and Prevention
Fortunately, when diagnosed and treated early, diphtheria is highly manageable. Medical interventions typically involve the administration of diphtheria antitoxin to neutralise the circulating toxin and antibiotics, such as penicillin or erythromycin, to eradicate the bacteria and halt further transmission. It is important to note that these treatments do not reverse damage already inflicted by the toxin, emphasizing the critical need for timely intervention. The most robust defense against diphtheria remains vaccination. Childhood immunisation provides strong, long-lasting protection, and recommended booster doses in adolescence and adulthood are essential for maintaining immunity. High vaccination coverage within a community is not only vital for individual protection but also plays a critical role in limiting the spread of the disease and preventing outbreaks.
India's Vaccination Push
In light of increasing global and regional concerns regarding diphtheria, India has intensified its vaccination strategies. Union Health Minister Jagat Prakash Nadda recently introduced an indigenously manufactured Tetanus and Adult Diphtheria (Td) vaccine. This initiative is specifically designed to enhance immunisation coverage among adults, a demographic that may have gaps in their vaccination history and is therefore more vulnerable to infections like diphtheria. By bolstering adult immunity, India aims to build a stronger barrier against the resurgence of preventable diseases and ensure greater protection for its population, complementing existing childhood immunisation programs.
